A new Opioid/Controlled Substance Dashboard was recently released by the Kansas Medical Mutual Insurance Company (KAMMCO) http://www.KAMMCO.com to help physicians, hospitals, and behavioral health providers participate in KAMMCO’s network of HIEs. The tool supplements the existing Prescription Drug Monitoring Program (PDMP) currently available in most states.
Laura McCrary, Senior Vice President of KAMMCO notes, “The KAMMCO tool builds upon a more comprehensive set of data than the PDMP which only captures filled prescription data and does not include medications which are administered to patients in healthcare facilities.”
The new dashboard provides participating clinicians with the list of opioids controlled substances prescribed or administered to a clinician’s patient even before a prescription is filled at the pharmacy. The tool uses data from the KAMMCO network of health information exchanges and is available to prescribing providers and their designated delegates.
The KAMMCO Analytics and Business Intelligence team worked with a multidisciplinary group of practicing physicians to access how HIE data could be used to better inform physicians regarding their patients’ history of opioid controlled substance use.
The tool enables clinicians to identify individuals in their patient population who received at least one prescription administration of opioids controlled substances by facility and date and also displays the top five opioid medications prescribed and/or administered to their patients.
Additional analytic dashboards available to KAMMCO network participants include information on high-risk patients, 30 day readmissions, disease registries, healthcare utilization, behavioral health, and preventive care quality reporting.